The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Dendreon; Genomic Health; Sanofi
Consulting or Advisory Role - Dendreon; Genomic Health; Sanofi
Immune responses and clinical outcomes in STAND, a randomized phase 2 study evaluating optimal sequencing of sipuleucel-T (sip-T) and androgen deprivation therapy (ADT) in biochemically-recurrent prostate cancer (BRPC) after local therapy failure.
 
Emmanuel S. Antonarakis
Honoraria - Dendreon; Janssen Biotech; Medivation; Sanofi
Consulting or Advisory Role - Dendreon; Janssen Biotech; Medivation; Sanofi
Research Funding - Aragon Pharmaceuticals (Inst); Dendreon (Inst); Exelixis (Inst); Genentech (Inst); Janssen Biotech (Inst); Johnson & Johnson (Inst); Millennium (Inst); Novartis (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Dendreon; Medivation; Sanofi
 
Adam S. Kibel
No Relationships to Disclose
 
George W. Adams
Consulting or Advisory Role - Cardinal Health
 
Lawrence Ivan Karsh
Stock and Other Ownership Interests - Swan Medical
Honoraria - Astellas Pharma; Bayer; Dendreon; Janssen; Medivation
Consulting or Advisory Role - Astellas Pharma; Dendreon; Genomic Health; Janssen; Medivation; Myriad Pharmaceuticals
Speakers' Bureau - Astellas Pharma; Dendreon; Medivation
Research Funding - Amgen; Aquinox; Argos Therapeutics; Augmenix; Auxilium; Dendreon; Evidera; FKD Therapies; Genomic Health; Janssen; Medivation; Myriad Pharmaceuticals; Nymox; Orion; Pfizer; Takeda
Expert Testimony - Takeda
 
Aymen Elfiky
Stock and Other Ownership Interests - Pfizer
Consulting or Advisory Role - McKinsey & Company; QPID Health
 
Neal D. Shore
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Ferring; Janssen; Millennium; Pfizer; Sanofi
Research Funding - Carolina Urologic Research Center
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Dendreon; Ferring; Janssen; Millennium; Pfizer; Sanofi
 
Nicholas J. Vogelzang
Employment - US Oncology
Stock and Other Ownership Interests - Caris Life Sciences
Honoraria - Abbvie; Bavarian Nordic; Dava Oncology; Endocyte; Mannkind; UpToDate
Consulting or Advisory Role - Amgen; AVEO; BIND Biosciences; Janssen Biotech
Speakers' Bureau - Bayer; Caris MPI; Dendreon; GlaxoSmithKline; Medivation; Millennium; Sanofi
Research Funding - Endocyte (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Parexel (Inst); Progenics (Inst); US Oncology (Inst); Viamet Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bayer/Onyx; Celgene; Dendreon; Exelixis; Genentech/Roche; Novartis; Pfizer; US Oncology
 
John M. Corman
Research Funding - Dendreon
 
Johnathan Cartwright Maher
Employment - Dendreon
Stock and Other Ownership Interests - Dendreon
 
Todd DeVries
Employment - Dendreon
Stock and Other Ownership Interests - Dendreon
Consulting or Advisory Role - KinDex
 
Candice McCoy
Employment - Dendreon
Stock and Other Ownership Interests - Dendreon
 
Nadeem A. Sheikh
Employment - Dendreon
Stock and Other Ownership Interests - Dendreon
Patents, Royalties, Other Intellectual Property - Dendreon
 
Charles G. Drake
Stock and Other Ownership Interests - Compugen; ImmuneXcite
Consulting or Advisory Role - Bristol-Myers Squibb; Compugen; Dendreon; ImmuneXcite; Janssen; Pfizer; Roche Pharma AG
Research Funding - Aduro Biotech; Bristol-Myers Squibb; Janssen